SCHEMBL4675787

SCHEMBL4675787

O=C(C=C(O)c1nc[nH]n1)c1ccoc1Cc1ccccc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KDM4E B2RXH2 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NR3C2 P08235 1/20 0.31
RAB9A P51151 1/20 0.31
BRS3 P32247 1/20 0.31
CYP1A1 P04798 1/20 0.31
ABCB1 P08183 1/20 0.31
CYP1B1 Q16678 1/20 0.31
AR P10275 1/20 0.31
KDM5A P29375 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
HCAR3 P49019 1/20 0.30
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4676607 0.88 LMNA (0.33) ALDH1A1BRS3KDM5BTP53
SCHEMBL4674056 0.87 GPR52 (0.35) ALDH1A1MAPTTSHRKDM4ENR3C2
SCHEMBL4677650 0.86 TP53 (0.35) ALDH1A1HPGDMAPTTSHRMEN1
SCHEMBL4675705 0.86 NPC1 (0.41) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL4677069 0.85 KMT2A (0.33) ALDH1A1HPGDMAPTTSHRMEN1
SCHEMBL4675794 0.84 ALDH1A1 (0.37) ALDH1A1HPGDMAPTTSHRMEN1
SCHEMBL4671946 0.83 TP53 (0.33) ALDH1A1HPGDKMT2AKDM4ENR3C2
SCHEMBL5899392 0.83 HCAR2 (0.39) ALDH1A1MAPTNR3C2BRS3KDM5A
SCHEMBL5899351 0.82 MEN1 (0.34) ALDH1A1HPGDMEN1KMT2ARXFP1
SCHEMBL4673098 0.82 L3MBTL1 (0.39) ALDH1A1MAPTRAB9ACYP1A1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 ALDH1A1 980/4885HPGD 2816/4885MAPT 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.